Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Oncology
Filter     Order     Display # 
Date Item Title
20 Aug 2008 Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma
20 Aug 2008 CEL-SCI Announces Exclusive Licensing Agreement With TEVA for Cancer drug Multikine
19 Aug 2008 Introgen's ADVEXIN(R) MAA Accepted for Review by European Medicines Agency
19 Aug 2008 Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy
19 Aug 2008 Progen resumes phase 1 development of anti-cancer agent,PG11047, in combination
18 Aug 2008 SymBio Pharmaceuticals and Eisai Sign License Agreement for bendamustine hydrochloride (SyB L-0501)
18 Aug 2008 Bioniche Phase III Clinical Trial in Bladder Cancer Progressing Well
16 Aug 2008 Evidence of activity seen in new data from ASA404 prostate cancer trial
16 Aug 2008 Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab
14 Aug 2008 Dendreon Initiates Second of Two New Phase 2 Trials
13 Aug 2008 Global Phase 3 Study of IMC-1121B in Metastatic Breast Cancer Commences
13 Aug 2008 Morphotek(R), Inc. Announces License Agreement for the Development of a Monoclonal Antibody to Treat Prostate Cancer
12 Aug 2008 Algeta begins first US clinical trial of Alpharadin in men with advanced prostate cancer
12 Aug 2008 Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma
12 Aug 2008 Threshold Pharmaceuticals Initiates a Second Clinical Trial Evaluating TH-302 in Patients With Solid Tumors
11 Aug 2008 Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
11 Aug 2008 Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
11 Aug 2008 WILEX starts patient recruitment in Phase II breast cancer trial with its uPA inhibitor MESUPRON(R) (WX-671)
10 Aug 2008 Geron Initiates Clinical Trial of GRN163L in Combination with Paclitaxel and Bevacizumab in Patients with Breast Cancer
07 Aug 2008 GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin
07 Aug 2008 Sonus Pharmaceuticals Signs Exclusive In-Licensing Agreement With Bayer Healthcare for Caspase Activator Compounds
07 Aug 2008 InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
06 Aug 2008 ARIAD Announces Start of Phase 2 Clinical Study of Oral Deforolimus in Patients with Advanced Endometrial Cancer
06 Aug 2008 Lorus Toxicology Program Supports Novel Route of Administration of the Anticancer Drug LOR-2040 in Bladder Cancer
05 Aug 2008 Infinity Highlights Clinical Advances in Its Portfolio of Anti-Chaperone Agents and Announces Second Quarter Financial Results
05 Aug 2008 YM Biosciences Reports Phase II Data for Nimotuzumab in Metastatic Colorectal Cancer
05 Aug 2008 Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105
31 Jul 2008 Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
31 Jul 2008 Seattle Genetics Initiates SGN-70 Phase I Clinical Trial
31 Jul 2008 Aegera Initiates a Fifth Phase 1 and 2 Clinical Trial for AEG35156
31 Jul 2008 Preliminary Cerepro Phase III Results Meet Primary Endpoint
30 Jul 2008 Infinity Initiates Clinical Development of IPI-493, Its Oral Anti-Chaperone Agent, in Patients With Advanced Solid Tumors
30 Jul 2008 ARIAD Announces Start of Phase 2 Clinical Trial of Oral Deforolimus in Patients with Metastatic, HER2-Positive Breast Cancer
30 Jul 2008 Hollis-Eden Pharmaceuticals Commences Phase I/II Clinical Trial with APOPTONE(TM) (HE3235) in Late-Stage Prostate Cancer Patients
28 Jul 2008 Momenta Pharmaceuticals Announces Results from M118 Drug-Drug Interaction Study with Aspirin and Clopidogrel
28 Jul 2008 GPC Biotech Reports that Marketing Authorization Application for Satraplatin is to be Withdran
28 Jul 2008 GTx Announces Phase III Clinical Development of Toremifene 20 mg on Course Following Planned Safety Review
28 Jul 2008 Nexavar Approved for Treatment of Liver Cancer in China
28 Jul 2008 Millennium Advances Oncology Pipeline
28 Jul 2008 Nventa Announces Final Data From HSPE7 Phase I Cervical Dysplasia Trial
26 Jul 2008 Ceplene(R) Receives Positive European Opinion for Approval From CHMP
24 Jul 2008 Patient recruitment in Phase II trial with MESUPRON(R) (WX-671) in pancreatic cancer patients successfully completed
24 Jul 2008 Cornerstone Pharmaceuticals Announces Approval to Conduct Phase I/II Clinical Trial of CPI-613 in Cancer Patients by US FDA
24 Jul 2008 Progen Terminates Pathway Trial & Confirms Focus on Potencial High Value Molecules and M&A
24 Jul 2008 Phase IV post marketing study results for Totect(R) accepted by the FDA
23 Jul 2008 APOSENSE(R) [18F]-ML-10 for Molecular Imaging of Apoptosis to Proceed to Phase I/II Trials
23 Jul 2008 MethylGene and Celgene Announce Precautionary Suspension of New Enrollments Into MGCD0103 Clinical Trials
23 Jul 2008 ADVEXIN(R) Shows Statistically Significant Six-Month and Overall Survival Benefit as Compared to Methotrexate in Prospectively Defined Biomarker Patient Population
23 Jul 2008 ZIOPHARM Presents Safety and Preliminary Efficacy Data from Two Phase I Studies of Indibulin at AACR Centennial Conference
22 Jul 2008 IRX Therapeutics Announces Results of Phase 2 Study for IRX-2
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 201 - 250 of 2757

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics